. 2006 Aug;80(16):7799–7806. doi: 10.1128/JVI.00318-06

TABLE 1.

Immunizations producing serum titers and monoclonal antibodies

Animal	Immunization route and immunogen^a	End point infected cell titer for strain (subgroup) determined by^b:				MAb obtained
		ELISA		Microneutralization
		NL100 (A1)	NL199 (B1)	NL100 (A1)	NL199 (B1)
Hamster	i.n. NL1700	1:781,250	1:781,250	1:1,250	<1:50	1017
	i.n./i.p. PIV3/F_NL100					757
Hamster	i.n. NL199	1:25,600	1:25,600	1:100	1:800	836
	i.n. NL100					659
	i.p. adeno F_NL100/F_NL199					967
	i.p. soluble F_NL100/F_NL199
Mouse	i.n. NL199	1:312,500	1:312,500	1:100	1:200	338
	i.n. PIV3/F_NL100					234
	i.p. adeno F_NL100/F_NL199					224
	i.p. soluble F_NL100/F_NL199
Mouse	i.n. NL199	1:312,500	1:312,500	1:50	1:1,600	710
	i.n. NL100					344
	i.p. adeno F_NL100/F_NL199					628
	i.p. soluble F_NL100/F_NL199

Immunization routes were intranasal (i.n.) and intraperitoneal (i.p.).

End point titers were determined as described in Materials and Methods.